Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 97

Sort by

Sort Order Select

Journal Articles

Ferritin change and predictors of anemia response in ruxolitinib-intolerant myelofibrosis patients treated with gecacitinib

Yi Zhang, Hu Zhou, Zhijian Xiao, Minghui Duan, Sujun Gao, Guangsheng He, Hongmei Jing, Junmin Li, Liangming Ma, Huanling Zhu, Chunkang Chang, Xin Du, Mei Hong, Xin Li, Qingchi Liu, Wei WANG, Na Xu, Haiping Yang, Jie Jin

Blood (2025) 146 (Supplement 1): 2029.

https://doi.org/10.1182/blood-2025-2029

Published: 2025

Journal Articles

Targeting the sanctuary sites: Allogeneic CD19 CAR-T therapy for extramedullary relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Rui Liu, Jian Zhang, Qian Cheng, Fangping Chen, Rong He, Xin Li

Blood (2025) 146 (Supplement 1): 1547.

https://doi.org/10.1182/blood-2025-1547

Published: 2025

Journal Articles

Ponatinib alleviates CAR-T cell exhaustion and remodels the immune microenvironment: A promising combination strategy for relapsed/refractory b-ALL

Yi Zhou, Liwen Wang, Linzhi Xie, Qian Cheng, Jing Liu, Fangping Chen, Rong He, Xin Li

Blood (2025) 146 (Supplement 1): 2331.

https://doi.org/10.1182/blood-2025-2331

Published: 2025

Journal Articles

Efficacy, safety, and T-cell population dynamics of glofitamab monotherapy in relapsed/refractory B-cell lymphoma

Xin Li, Rui Cui, Jia Wang, Yao Qi, Shuquan Gao, Tingting Zhu, Jingyi Li, QI Deng

Blood (2025) 146 (Supplement 1): 7266.

https://doi.org/10.1182/blood-2025-7266

Published: 2025

Journal Articles

Genotype-guided comparison of ven-HMA versus intensive chemotherapy in newly diagnosed intermediate-risk AML: A multicenter real-world study

XIN CHEN, yuhan yan, Qian Cheng, yishu tang, ying Li, han xiao, erhua wang, jian zhang, Liwen Wang, qin zhang, Rong He, Fangping Chen, Xin Li

Blood (2025) 146 (Supplement 1): 3452.

https://doi.org/10.1182/blood-2025-3452

Published: 2025

Journal Articles

Validation of the boscore model for predicting invasive mold disease in Chinese patients with hematological malignancies undergoing chemotherapy: A single-center retrospective study

Minghui Duan, Wen-xin Li

Blood (2025) 146 (Supplement 1): 7947.

https://doi.org/10.1182/blood-2025-7947

Published: 2025

Journal Articles

A tandem bispecific nanobody CAR (SL1703) T cells targeting CD19/BCMA for refractory or relapsed multiple myeloma as salvage treatment after BCMA CAR-T therapy failure

Su Li, Xin Li, Chengwei Jin, Wei Liu, Yan Zhao, Jingjing Wang, Chun Wang, Jian Hou, Jing PAN

Blood (2025) 146 (Supplement 1): 5934.

https://doi.org/10.1182/blood-2025-5934

Published: 2025

Journal Articles

Long-term follow-up of patients with relapsed b-ALL after allo-HSCT treated with CD19 CAR-T cell from recipients and donors

Jia Wang, Siyan Niu, Can Liu, Xin Li, Qing Li, Yao Qi, Jingyi Li, QI Deng

Blood (2025) 146 (Supplement 1): 7670.

https://doi.org/10.1182/blood-2025-7670

Published: 2025

Journal Articles

Phase 3 ESLIM-01 study: Final analysis of efficacy and safety of long-term treatment with sovleplenib in adults with chronic primary immune thrombocytopenia

Blood (2025) 146 (Supplement 1): 843.

https://doi.org/10.1182/blood-2025-843

Published: 2025

Journal Articles

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Blood (2025) 146 (Supplement 1): 6293.

https://doi.org/10.1182/blood-2025-6293

Published: 2025

Journal Articles

Long-term treatment continuation of gecacitinib in myelofibrosis patients after ruxolitinib failure

Blood (2025) 146 (Supplement 1): 5584.

https://doi.org/10.1182/blood-2025-5584

Published: 2025

Journal Articles

Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma

Blood (2025) 145 (17): 1876–1889.

https://doi.org/10.1182/blood.2024025694

Published: 2025

Includes: Supplemental data

Journal Articles

A Phase Ib/II Clinical Trial of Linperlisib Combined with Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-Cell Lymphoma: Analysis of the Phase Ib Part

Lei Yang, Xin Li, Jia Cong, Liang Wang

Blood (2024) 144 (Supplement 1): 6413.

https://doi.org/10.1182/blood-2024-207469

Published: 2024

Journal Articles

Outcomes and Prognostic Factors of the Alternative Regimens for Angioimmunoblastic T Cell Lymphoma: A Retrospective Study

Jiaqin Yan, Bingjie Wang, Yankui Wei, Shasha Zhang, Lei Zhang, Ling Li, Xin Li, Xiaorui Fu, Xinhua Wang, Zhenchang Sun, Xudong Zhang, Mingzhi Zhang

Blood (2024) 144 (Supplement 1): 6408.

https://doi.org/10.1182/blood-2024-206732

Published: 2024

Journal Articles

Limited Quality of Life Sacrifice for Optimizing Long-Term Survival: The Impact of p-Alg Compared to r-ATG in High-Risk Hematological Malignancy Patients Undergoing Matched Sibling Donor Transplantation

Qian Cheng, Lingyan Yan, Xin Li

Blood (2024) 144 (Supplement 1): 7359.

https://doi.org/10.1182/blood-2024-203026

Published: 2024

Journal Articles

Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymphoma on Behalf of the Chinese Ocular Lymphoma Collaborative Group (COLCG)

Xin Li, Jia Wei, Dong-feng Zeng, Shu-nan Qi, Bingzong Li, Wei Guo, Li Wang, Yajun Li, Xudong Zhang, Yong Yang, Shukai Qiao, Yan Zeng, Yunfei Song, Jing-wen Wang, Jian-min Ma, Liang Wang

Blood (2024) 144 (Supplement 1): 4418.

https://doi.org/10.1182/blood-2024-206489

Published: 2024

Journal Articles

Targeting of the CD161 Inhibitory Receptor Enhances Bone Marrow-Resident Memory CD8 + T Cell-Mediated Immunity Against Multiple Myeloma

Liwen Wang, Linzhi Xie, Yi Zhou, Yan Yu, Shiming Tan, Qian Cheng, Rong He, Xin Li

Blood (2024) 144 (Supplement 1): 3291.

https://doi.org/10.1182/blood-2024-198964

Published: 2024

Journal Articles

Long-Term Efficacy Observation of Anti-BCMA CAR-T Cell Therapy Combined with Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma with Extramedullary Disease

QI Deng, Xin Li, Qing Li, Jia Wang, Juan Mu, Rui Cui

Blood (2024) 144 (Supplement 1): 4763.

https://doi.org/10.1182/blood-2024-205268

Published: 2024

Journal Articles

Pretreatment with BTK Inhibitors Could Improve the Sensitivity of DLBCL Cells to CAR-T Cells in Co-Culture System By Down-Regulating the Polarization of M2 Macrophages

Yao Qi, Jia Wang, Xin Li, Juan Mu, Rui Cui, QI Deng

Blood (2024) 144 (Supplement 1): 1625.

https://doi.org/10.1182/blood-2024-206729

Published: 2024

Journal Articles

Orelabrutinib with or without Anti-CD20 Monoclonal Antibodies Is Highly Effective and Well Tolerated As First-Line Therapy for Marginal Zone B Cell Lymphoma

Na Yao, Xin Li, Jing Yang, Jia Cong, Liang Wang

Blood (2024) 144 (Supplement 1): 6541.

https://doi.org/10.1182/blood-2024-203548

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Ferritin change and predictors of anemia response in ruxolitinib-intolerant myelofibrosis patients treated with gecacitinib

Targeting the sanctuary sites: Allogeneic CD19 CAR-T therapy for extramedullary relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Ponatinib alleviates CAR-T cell exhaustion and remodels the immune microenvironment: A promising combination strategy for relapsed/refractory b-ALL

Efficacy, safety, and T-cell population dynamics of glofitamab monotherapy in relapsed/refractory B-cell lymphoma

Genotype-guided comparison of ven-HMA versus intensive chemotherapy in newly diagnosed intermediate-risk AML: A multicenter real-world study

Validation of the boscore model for predicting invasive mold disease in Chinese patients with hematological malignancies undergoing chemotherapy: A single-center retrospective study

A tandem bispecific nanobody CAR (SL1703) T cells targeting CD19/BCMA for refractory or relapsed multiple myeloma as salvage treatment after BCMA CAR-T therapy failure

Long-term follow-up of patients with relapsed b-ALL after allo-HSCT treated with CD19 CAR-T cell from recipients and donors

Phase 3 ESLIM-01 study: Final analysis of efficacy and safety of long-term treatment with sovleplenib in adults with chronic primary immune thrombocytopenia

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Long-term treatment continuation of gecacitinib in myelofibrosis patients after ruxolitinib failure

Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma

A Phase Ib/II Clinical Trial of Linperlisib Combined with Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-Cell Lymphoma: Analysis of the Phase Ib Part

Outcomes and Prognostic Factors of the Alternative Regimens for Angioimmunoblastic T Cell Lymphoma: A Retrospective Study

Limited Quality of Life Sacrifice for Optimizing Long-Term Survival: The Impact of p-Alg Compared to r-ATG in High-Risk Hematological Malignancy Patients Undergoing Matched Sibling Donor Transplantation

Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymphoma on Behalf of the Chinese Ocular Lymphoma Collaborative Group (COLCG)

Targeting of the CD161 Inhibitory Receptor Enhances Bone Marrow-Resident Memory CD8 + T Cell-Mediated Immunity Against Multiple Myeloma

Long-Term Efficacy Observation of Anti-BCMA CAR-T Cell Therapy Combined with Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma with Extramedullary Disease

Pretreatment with BTK Inhibitors Could Improve the Sensitivity of DLBCL Cells to CAR-T Cells in Co-Culture System By Down-Regulating the Polarization of M2 Macrophages

Orelabrutinib with or without Anti-CD20 Monoclonal Antibodies Is Highly Effective and Well Tolerated As First-Line Therapy for Marginal Zone B Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only